This month, the cancer center hosted a conference with medical physicists and leaders in cancer technology from around the world. Here's how it will impact Louisiana.

DelveInsight's "FYARRO Market Size, Forecast, and Market Insight Report" highlights the details around FYARRO, an mTOR inhibitor. The report provides product descriptions, patent details, and ...

FYARRO holds strong market potential, particularly in treating rare and aggressive cancers like PEComa, where treatment options are limited. As the first FDA-approved therapy for advanced PEComa ...

Eddie Kolos, Founder & CEO of H2Ocean, with Dr. Rajiv Saini, Chief Scientific Officer, H2Ocean, at The University of Texas MD Anderson Cancer Cent ...

Breast cancer is the leading cause of cancer death among Latinas. Testing for breast density and other risk factors can save ...

More than 1800 women told us their stories of medical misogyny. Today we begin sharing those stories and building the case ...

Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized ...

USC Norris opens a Newport Beach radiation oncology and imaging center, the first in Orange County to offer innovative ...

The Bucks County baby who made international headlines almost 10 years ago when she was kissed by Pope Francis is now a ...